National Prescription Opiate / Opioid Litigation

The National Prescription Opiate Litigation, coordinated as MDL No. 2804 in the Northern District of Ohio, became one of the largest and most complex mass tort cases in U.S. history. Thousands of plaintiffs — including state attorneys general, counties, cities, and Native American tribes — alleged that pharmaceutical manufacturers like Johnson & Johnson aggressively and deceptively marketed opioid painkillers as safe and non-addictive, while distributors like McKesson, AmerisourceBergen, and Cardinal Health (the "Big Three") ignored obvious red flags and flooded communities with billions of pills. The opioid epidemic has claimed over 500,000 American lives since 1999, devastating families and straining public health and law enforcement resources nationwide.

After years of litigation and bellwether trials, the case produced a landmark $26 billion settlement in 2021 with the three major distributors and Johnson & Johnson, one of the largest civil settlements in U.S. history. The funds are being distributed over 18 years and are earmarked specifically for addiction treatment, recovery programs, and prevention efforts. Additional settlements followed with pharmacy chains including CVS, Walgreens, and Walmart, bringing total opioid settlement dollars to well over $50 billion. The case set a powerful legal and legislative precedent for corporate accountability in the public health crisis.